The cardiorespiratory effects of etomidate were measured in two groups of six patients with aortic or mitral valve disease. The induction of anaesthesia with etomidate 0.3 mg kg" 1 was followed by a second dose 10 min later. After the first dose, a 19% decrease in systemic arterial pressure was associated with a decrease in systemic vascular resistance and left ventricular heart work. Cardiac index, pulmonary artery pressure and wedge pressure all decreased slightly. Central venous pressure and heart rate did not change. A slight increase in respiratory frequency failed to prevent an increase in Paco,-Changes after the second dose were similar. The two groups of patients did not differ significantly in their response to etomidate. No patient complained of pain during injection, nor did myoclonic movements occur.
Etomidate is associated with minimal changes in the cardiovascular system (Doenicke, Kugler et al., 1973; Doenicke, Wagner and Beetz, 1973; Holdcroft et al., 1976) , and could be suitable for the induction of anaesthesia in patients with cardiac disease.
In this study, measurements were made of the cardiorespiratory changes that occurred during the induction of anaesthesia before cardiac surgery in patients with aortic or mitral valve disease. Since one dose at induction might reflect only the physiological changes associated with the onset of unconsciousness, a second identical dose of the drug was given 10 min after the first, but before the patient regained consciousness.
PATIENTS AND METHODS
All the patients in the study were about to undergo cardiac surgery and were divided into two groups. Six patients had predominantly aortic valve disease and six predominantly mitral valve disease (table I) . Patients with obvious heart failure, angina or a resting systemic arterial pressure greater than 150/90 mm Hg were excluded. 
Premedication
At the visit before operation, the cannulation procedure was explained to the patient and written consent to use etomidate obtained. Papaveretum 0.3 mg kg" 1 and promethazine 0.7 mg kg" 1 i.m. were administered as premedication and, at the surgeon's request, digoxin 0.25 mg and antibiotics were given at the same time. In each group, three patients received ampicillin 250 mg and cloxacillin 250 mg and three received gentamicin 80 mg and flucloxacillin 250 mg.
Procedure
The patient was made comfortable on the operating table, the e.c.g. leads attached, a chest stethograph positioned and oxygen administered through an M.C. face mask.
Under local anaesthesia a Swan-Ganz catheter (7 f.g.) was positioned in the pulmonary artery via the right internal jugular vein, and the left femoral artery cannulated for measurement of arterial pressure. Details of the cannulation procedure have been described previously (Savege et al. 3 1976) .
When the patient had rested for 15 min, control measurements were made over a 5-min period and during this time at least three values for cardiac output were determined. Anaesthesia was induced by the injection of etomidate 0.3 mg kg" 1 i.v. over 60 s through an indwelling needle (19 f.g.) in the left hand. This dose had been recommended by the manufacturers and used in previous studies (Doenicke, Kugler et al., 1973; Morgan, Lumley and Whitwam, 1975; Holdcroft et al., 1976) . After lOmin of measurement a second dose of 0.3 mg kg" 1 was given over 60 s and measurement continued for a further 10 min.
Measurements, analysis and calculations
Systemic and pulmonary artery pressures, central venous pressure and, at 1-min intervals, pulmonary artery wedge pressure were recorded continously and were subsequently measured from the trace every 12 s. Groups of five readings in each minute were used to calculate "minute means".
Heart rate and respiratory frequency were counted from this continuous trace. Cardiac output was determined every 2 min by thermodilution using a Devices cardiac output computer. Blood-gas tensions were measured in all patients. After a control sample, further samples were taken 3, 6 and 9 min after the injection of each dose of etomidate.
Surface area, cardiac index, stroke index, mean arterial pressure, vascular resistance and ventricular minute work index were calculated from established formulae using a Hewlett-Packard 9810 A Calculator. Control values for the first injection were obtained over a 5-min period; control values for the second injection were those measured over the immediately preceding minute. The mean change in each variable was compared with the control value at 1-min intervals and tested for significance using Student's t test for correlated means.
A more detailed account of the method of obtaining measured and derived values can be found in a previous paper (Savege et al., 1976) .
RESULTS
The physical and clinical details of the two groups of patients are shown in 
Combined results for all 12 patients
Systemic arterial pressure (Jig. 1, table II). There was a statistically significant decrease in systolic and diastolic pressures of 19% in the first 4 min following the first dose of etomidate. These pressures remained at this level until the second dose was given, when a further decrease of 13% occurred after 2 min. Thereafter the pressure recovered slightly.
Pulmonary artery pressure {fig. 1, table If). After the first dose there was a slow decrease in mean pulmonary artery pressure to a maximum of 11 %. This was statistically significant only at 9 and 10 min. There was no change following the second dose.
There was a statistically significant decrease in pulmonary artery wedge pressure after 3 min by a maximum of 3 mm Hg. No further change occurred after the second dose.
Central venous pressure (CVP) . There was no change in CVP after either dose.
Heart rate ( fig. 1 , table II). There was no significant change in heart rate after either dose. There were no alterations in cardiac rhythm.
Cardiac and stroke index (fig. 2, table II).
After each dose, there were small decreases in cardiac index that were statistically significant 3 min after the first dose and 1 min after the second. The decrease in stroke index was even smaller and was not statistically significant. 
Systemic and pulmonary vascular resistances (fig. 2, table II).
After the first dose, the systemic vascular resistance increased at 1 min and then decreased steadily by a maximum of 17% at 5 min; this decrease was statistically significant. After the second dose, the increase at 1 min was even more marked (+23%) and was statistically significant. Following this there was a marked decrease at 3 min but thereafter resistance recovered to the control value by 10 min; these changes were not statistically significant.
Pulmonary vascular resistance increased by 27% at 3 min and then decreased slowly to control. The absolute increase was small and not statistically significant. After the second dose the smaller increase of 23% was statistically significant and remained increased slightly until the end of the period of measurement. Heart work ( fig. 2, table II) . After a small increase, left ventricular heart work decreased markedly and significantly at 3 min and thereafter there was a slow increase. Following the second dose there was a further decrease (15%) at 3 min, which was sustained.
Right ventricular work decreased slightly to a maximum at 3 min after each dose. It remained below control values for the rest of the recorded period.
Respiratory changes ( fig. 1, table III) . Following the first dose, respiratory frequency increased by two breaths per minute from the 3rd to the 6th minute. This increase was statistically significant.
After the second dose, the frequency decreased initially, but by the 3rd minute had increased again by 2 b.p.m.
Despite the small increase in respiratory rate, there was a statistically significant increase in -Pa C02 after each dose. Pa Oa did not change.
Other effects of etomidate. In all patients etomidate produced a rapid onset of anaesthesia. There were no instances of involuntary movements during induction. Despite the fact that the drug was injected into a vein in the back of the hand, no patient complained of pain during the injection of the drug.
Results separated into aortic and mitral groups
Figures 3 and 4 show how the 12 patients behaved when divided into the groups with predominantly aortic or mitral valve disease. Although the control values of the two groups often differed widely and the systemic arterial diastolic pressure of the aortic group was predictably less than in the mitral group, both groups responded similarly.
DISCUSSION
Previous investigations have emphasized how little etomidate affected the cardiovascular system (Doenicke, Kugler et al., 1973; Doenicke, Lorenz et al., 1973; Doenicke, Wagner and Beetz, 1973; Kettler et al., 1974; Holdcroft et al., 1976) . In only two studies have small decreases in arterial pressure, of 9% (Morgan, Lumley and Whitwam, 1975) and 8.5% (Rifat, Gamulin and Gemperle, 1976) , been noted. These observations would suggest that etomidate is the only i.v. induction agent that induces only minor changes in the cardiovascular system. Ketamine is unusual in that it increases muscle tone which may increase venous return and, in part, be responsible for the maintenance of, or increase in, arterial pressure. Etomidate has been shown also to cause involuntary movement and increased muscle tone after injection, with a reported frequency that has ranged between 18% (O'Carroll et al., 1977) and 60% (Holdcroft et al., 1976) . Rifat, Gamulin and Gemperle (1976) observed myoclonic movements in nine of 14 patients. In a study of cardiovascular variables in five patients receiving etomidate, Kettler and colleagues (1974) noted that movements made cardiovascular measurements difficult and it was necessary to hold down some of the patients, and it is difficult to understand how accurate measurements could be made under these circumstances. It is possible that etomidate has a stimulant action on the central nervous system which either maintains arterial pressure directly or maintains it indirectly as a result of the increase in muscle tone which causes an increase in the venous return to the heart.
In this present study, no movements were observed, probably because all the patients were heavily premedicated, a factor which has been shown to reduce the frequency of movements (Holdcroft et al., 1976) . Arterial pressure decreased by 19% after the first injection and by 13% after the second, both changes being statistically significant. As heart rate and cardiac index remained almost unchanged, it is likely that the decrease in arterial pressure was associated with vasodilatation as indicated by the decrease in systemic vascular resistance. No measurement of myocardial contractility was attempted and it is not possible, therefore, to say if this contributed also to the decrease in arterial pressure. The decrease in systemic vascular resistance would also account for the decrease in left ventricular work. Since all these changes reduced the work of the heart, they might be regarded as desirable in patients with cardiac disease, provided the decrease in arterial pressure is insufficient to compromise the coronary circulation.
The absence of any change in heart rate was in agreement with all previous studies except that by Doenicke, Lorenz and co-workers (1973) who reported an increase in heart rate of 60% in the first 2 min. In their study, however, atropine was given just before induction and may have been responsible for tachycardia. Premedication with digoxin may have prevented any changes in heart rate in the present study.
In contrast to other induction agents, etomidate caused a transient increase in respiratory frequency, which, however, was not enough to prevent an increase in ^ccv Table II compares the results of this study with previous investigations in which Althesin was given to a similar group of patients with cardiac disease (Savege et al., 1976) . The similarity between the maximum percentage changes in these two groups of patients following the injection of Althesin and etomidate is striking.
Pain on injection of etomidate into a small peripheral vein has been reported in up to 81% of patients (Holdcroft et al., 1976) . In this study, despite the use of a vein on the back of the hand, no patient complained of pain. This may have been a result of the slow rate of injection (over 1 min) or to premedication.
The comparison of the two groups of patients with predominantly aortic or mitral valve disease showed that the overall response to etomidate was almost identical in each group, despite the commonly held belief that they respond differently to the induction of anaesthesia.
Etomidate was found to be a reliable and effective agent for induction of anaesthesia, although in this group of patients it cannot be claimed that it offered any important advantages over the existing induction agents. Kettler, D., Sonntag, H., Donath, V., Regensburger, D., and Shenk, H. D. (1974) . Haemodynamics, myocardial function, oxygen requirements and oxygen supply of the human heart after the administration of etomidate. Anaesthesist, 23,116. Morgan, M., Lumley, J., and Whitwam, J. G. (1975 
VARIATIONS CARDIORESPIRATOIRES APRES INDUCTION DE L'ANESTHESIE PAR L'ETOMIDATE SUR DES MALADES SOUFFRANT DE CARDIOPATHIE

RESUME
On a mesure, sur deux groups de six malades souffrant de maladie de la valvule aortique ou de la valvule mitrale, les effets cardiorespiratoires de l'etomidate. L'induction de l'anesthesie a l'aide d'etomidate a raison de 0,3 mg kg" 1 a ete suivie d'une seconde dose 10 min plus tard. Apres la premiere dose, une baisse de 19% de la pression arterielle systemique a ete associee a la diminution de la resistance vasculaire systemique et au fonctionnement du ventricule gauch. L'index cardiaque, la pression de l'artere pulmonaire et la pression en coin ont legerement baisse. La pression veineuse centrale et le rythme cardiaque n'ont pas change. La l^gere augmentation de la frequence respiratoire n'a pas pu empecher une augmentation de la PSLCO,-Apres la seconde dose, les variations ont ete similaires. Les deux groups de malades n'ont pas ete tres differents dans leurs reactions a l'etomidate. Aucun malade ne s'est plaint de douleur pendant l'injection et il ne s'est produit aucun mouvement myoclonique. 
SUMARIO
Los efectos cardiorespiratorios del etomidato se midieron en dos grupos de seis pacientes que sufren de enfermedad de la valvula aortica o mitral. La induccion de la anestesia por medio de 0,3 mg kg" 1 de etomidato fue seguida, 10 min despues, por una segunda dosis. Tras la primera dosis, se produjo una disminucion del 19% en la presion sistemica arterial, junto con una reduccion de la resistencia vascular sistemica y de la funcion del ventriculo izquierdo del corazon. En cuanto al indice cardiaco, a la presi6n arterial pulmonar y a la presion de la curia, todos bajaron ligeramente. No se alteraron la presi6n venosa central ni el ritmo del corazdn. Un ligero aumento de la frecuencia respiratoria no pudo prevenir un incremento del P&co,-Las alteraciones fueron similares despues de la segunda dosis. No difieron de manera significativa las respuestas al etomidato de los dos grupos de pacientes. Ningiin paciente se quejo de sentir dolor durante la inyeccion, ni tampoco ocurrieron movimientos mioclonicos.
